AO L. Sacco
Milan, 20157, Italy
NCT Number: NCT02640352
The aim of the present study is to test the efficacy of the combination of two probiotic bacteria in reducing the severity of upper respiratory tract infections (common cold) in healthy children attending day care or school. The probiotic bacteria used are Lactobacillus plantarum strain DSM 15312 and Lactobacillus paracasei DSM 13434 at a total dose of 1 x 10^9 CFU/tablet and day and will be consumed for a period of 12 weeks.
Looking for future studies?
Notify Me3 year–7 year
All sexes
Interventional
Not applicable
Milan, 20157, Italy
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Children presenting one or more of the following criteria will not be eligible to enter the study.
Time frame: 12 weeks
Time frame: 12 weeks
Time frame: 12 weeks
Time frame: 12 weeks
Probi AB
Industry
A Randomized, Double Blind, Placebo-controlled Study to Investigate the Effect of a Probiotic Product on Acute Upper Respiratory Tract Infections (Common Cold) in Healthy Children
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07720583
Acute Pharyngitis, Acute Rhinitis
Karachi, Pakistan
View Trial DetailsNCT07267689
Cold Symptom, Common Cold
Kielce, Poland
View Trial DetailsNCT07511400
Acute Pain, Common Cold
Vienna, State of Vienna, Austria
View Trial DetailsNCT06223087
Behavior, Cold Exposure
Krakow, Poland
View Trial Details